A Message from Dr. Gulec, President & CEO
Seza Gulec, MD
Welcome to the new Miami Cancer Research Center website. Here you will be able to explore news, research, and educational opportunities to deepen your understanding of the complex world of cancer. I hope that together we will find new ways of meeting the needs of patients, families, and the medical community facing this difficult challenge.
Our most important learning opportunity will take place in just a few weeks and I invite you to join me at our 4th Annual Thyroid Cancer Symposium, this time in a virtual format due to the difficult times we are going through. Here is a glimpse of the program. Space is limited and I encourage you to register now.
As I reflect on this symposium, it is worth noting that we have entered a personalized medicine paradigm with molecular theranostics. We are defining cancer oncobiology based on genomic and epigenomic expressions. A clinical catalog for genetic alterations associated with cancer has been created using next-generation sequencing and bioinformatics. The approach to clinical issues, thus, has moved beyond conventional diagnostics and therapeutic interventions. The risk stratification systems based on traditional parameters are challenged, and they are gradually vacating their role to clear molecular markers. More refined classification schemes based on genomics and its phenotypic expressions are being formulated. Genomics with molecular pathology and molecular imaging reflect the true biologic nature of the different cancer types currently defined by conventional morphologic features. The tumor differentiation/de-differentiation, and clinical behavior for each cancer are now being defined by molecular markers, in addition to standard morpho-pathology. The technology is rapidly evolving and incorporated into daily practice.
The Miami Thyroid Oncology Symposium is a leading-edge forum for the advancement of the science of thyroid cancer diagnosis and treatment in this new paradigm. The program is designed as a two-day symposium. We are indebted to our world-renowned faculty for taking part in this exciting scientific symposium. We hope to fulfill our commitment to furthering the science of thyroid cancer towards the new frontiers.